costs related to supplies, materials, production labor and travel costs. Rental Revenue: As an owner and operator of real estate, the Company derives rental revenue from leasing office and parking space to tenants at its property.

filing / Jun 11, 2026 / receipt

supplies, materials, production labor and travel costs. General and administrative expenses for the Infusion Technology segment consist mainly of payroll, insurance, software and licenses.

filing / Jun 11, 2026 / receipt

Accrued severance expenses $ 797 $ 1,179 Accrued bonuses 767 814 Accrued professional fees 415 407 Accrued interest 248 235 Accrued clinical trial expense 381 571 Other accrued expenses 156 98 Total accrued expenses, current 2,764 3,304 Creditor payable, noncurrent - 3,602 Accrued severance, noncurrent - 293 Total accrued expenses, noncurrent $ - $ 3,895 Tot

filing / Jun 11, 2026 / receipt

The Company recognized $ 852,168 of severance expense during the three months ended July 31, 2025 related to the general release agreement with Fine which was included in general and administrative expense.

filing / Jun 11, 2026 / receipt

supplies, materials, production labor, and travel costs. General and administrative expenses for the Infusion Technology segment consist mainly of payroll, insurance, software, and licenses.

filing / Mar 16, 2026 / receipt

costs related to supplies, materials, production labor, and travel costs. Rental Revenue: As an owner and operator of real estate, the Company derives rental revenue from leasing office and parking space to tenants at its property.

filing / Mar 16, 2026 / receipt

Accrued severance expenses $ 916 $ 1,179 Accrued bonuses 560 814 Accrued professional fees 422 407 Accrued interest 243 235 Accrued clinical trial expense 401 571 Other accrued expenses 236 98 Total accrued expenses, current 2,778 3,304 Creditor payable, noncurrent 3,483 3,602 Accrued severance, noncurrent - 293 Total accrued expenses, noncurrent 3,483 3,895

filing / Mar 16, 2026 / receipt

The Company recognized $ 852,168 of severance expense during the year ended July 31, 2025 related to the general release agreement with Fine which was included in general and administrative expense.

filing / Mar 16, 2026 / receipt